Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown

被引:216
作者
Castillo, I
Pardo, M
Bartolomé, J
Ortiz-Movilla, N
Rodríguez-Iñigo, E
de Lucas, S
Salas, C
Jiménez-Heffernan, JA
Pérez-Mota, A
Graus, J
López-Alcorocho, JM
Carreño, V
机构
[1] Fdn Estudio Hepatitis Virales, Madrid 28015, Spain
[2] Clin Puerta Hierro, Dept Pathol, Madrid, Spain
[3] Hosp Zarzuela, Dept Pathol, Madrid, Spain
[4] Hosp Virgen Torre, Digest Dept, Madrid, Spain
关键词
D O I
10.1086/380202
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. There are patients in whom the etiology of long-standing abnormal results of liver-function tests is unknown (ALF-EU) after exclusion of all known causes of liver diseases. We analyzed the presence of hepatitis C virus (HCV) RNA in liver-biopsy specimens from 100 patients who were negative for anti-HCV antibodies and for serum HCV RNA and who had ALF-EU. Methods. HCV RNA status was tested by reverse-transcription polymerase chain reaction (RT-PCR) and by in situ hybridization, in liver and peripheral-blood mononuclear cells (PBMCs). Results. HCV RNA was detected in liver-biopsy specimens from 57 of 100 patients negative for anti-HCV antibodies and for serum HCV RNA (i.e., who had occult HCV infection). HCV RNA of negative polarity was found in the liver of 48 (84.2%) of these 57 patients with occult HCV infection. Nucleotide-sequence analysis confirmed the specificity of detection of HCV RNA and that patients were infected with the HCV 1b genotype. Of these 57 patients with intrahepatic HCV RNA, 40 (70%) had viral RNA in their PBMCs. With regard to liver histology, patients with occult HCV infection were more likely to have necroinflammatory activity (P=.017) and fibrosis (P = .022) than were patients without intrahepatic HCV RNA. Conclusion. Patients with ALF-EU may have intrahepatic HCV RNA in the absence of anti-HCV antibodies and of serum HCV RNA.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 33 条
[21]   Use and interpretation of virological tests for hepatitis C [J].
Pawlotsky, JM .
HEPATOLOGY, 2002, 36 (05) :S65-S73
[22]   Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage [J].
Quiroga, JA ;
Martín, J ;
Navas, S ;
Carreño, V .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :247-251
[23]   Histological damage in chronic hepatitis C is not related to the extent of infection in the liver [J].
Rodríguez-Iñigo, E ;
Bartolomé, J ;
de Lucas, S ;
Manzarbeitia, F ;
Pardo, M ;
Arocena, C ;
Gonsálvez, J ;
Oliva, H ;
Carreno, V .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06) :1877-1881
[24]  
Rodríguez-Iñigo E, 2000, J MED VIROL, V60, P269, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt
[25]  
269::AID-JMV4&gt
[26]  
3.0.CO
[27]  
2-1
[28]   Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 [J].
Rubbia-Brandt, L ;
Quadri, R ;
Abid, K ;
Giostra, E ;
Malé, PJ ;
Mentha, G ;
Spahr, L ;
Zarski, JP ;
Borisch, B ;
Hadengue, A ;
Negro, F .
JOURNAL OF HEPATOLOGY, 2000, 33 (01) :106-115
[29]   Demonstration and distribution of HCV RNA sequences by in situ hybridization and HCV-related proteins by immunohistochemistry in the liver tissue of patients with chronic HCV infection [J].
Sansonno, D ;
Cornacchiulo, V ;
Iacobelli, AR ;
Gatti, P ;
DiStasi, M ;
Dammacco, F .
PATHOBIOLOGY, 1995, 63 (05) :239-248
[30]   STRUCTURE AND ORGANIZATION OF THE HEPATITIS-C VIRUS GENOME ISOLATED FROM HUMAN CARRIERS [J].
TAKAMIZAWA, A ;
MORI, C ;
FUKE, I ;
MANABE, S ;
MURAKAMI, S ;
FUJITA, J ;
ONISHI, E ;
ANDOH, T ;
YOSHIDA, I ;
OKAYAMA, H .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1105-1113